NOTTINGHAM, England--(BUSINESS WIRE)--Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards ...

On Tuesday, Dec. 30, the TLC series aired the last episode of Season 2, during which Baylen, her fiancé, Colin Dooley, and her family traveled to the U.K. to test out a new Tourette syndrome treatment ...

Two technologies that are based on research by University of Nottingham experts to reduce the severity of tics in people with Tourette syndrome (TS) are closer to patient use after being recommended ...

A wrist device for people with Tourette's syndrome has been described as "life-changing". The Neupulse aims to reduce the symptoms by delivering electrical stimulation directly into nerves in the ...

A wrist device tested by Scottish singer Lewis Capaldi has been shown to reduce tics in those with Tourette's syndrome. The Neupulse device, developed by the University of Nottingham, delivers ...

Neupulse, a neurotherapeutics company developing solutions for brain health conditions such as Tourette's syndrome, has raised £3m to accelerate its path to market. The funding round was led by Eos ...

The device, called Neupulse, works by stimulating a motor nerve in the arm with rhythmic electrical pulses that trigger brain oscillations linked to the suppression of movement. In a trial of 121 ...

The National Institute for Health and Care Excellence (NICE) has approved two technologies for treating chronic tic disorders and Tourette syndrome. The Online Remote Behavioural Intervention for Tics ...

NICE's medical technologies advisory committee considered evidence on digital therapy for chronic tic disorders and Tourette syndrome from several sources, including an early value assessment report ...

NICE's assessment of digitally enabled therapy for chronic tic disorders and Tourette syndrome considered the Neupulse technology. This plan outlines the evidence gaps and what data needs to be ...